The VanEck Biotech ETF (BBH) and Vanguard Health Care ETF (VHT) serve distinct strategies within the healthcare sector. BBH focuses on a concentrated biotech portfolio with 25 holdings, offering higher potential rewards but at greater risk and volatility. Conversely, VHT provides broader exposure across over 400 healthcare stocks, emphasizing low-cost diversification and stability.
As of mid-2026, VHT boasts a lower expense ratio (0.09%) and a higher dividend yield (1.6%), alongside its robust total return of 159% over the last decade. BBH, with an expense ratio of 0.35%, delivered a total return of 87% in the same period. Overall, VHT is suited for conservative investors seeking steady income, while BBH may attract those willing to navigate the volatility of biotech for potentially higher gains.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.fool.com/coverage/etfs/2026/07/28/vanguard-health-care-etf-outperforms-vaneck-biotech-on-returns-yield-and-fees/
